And 58.2% (78 out of 134) glioma tissue samples showed high expression of CCAT2 mRNA compared with that adjacent normal tissues, while 11.9% (16 out of 134) tissues showed no change (Figure 1B). This evidence concerns the gene CCAT2 and central nervous system cancer.